Telix Pharmaceuticals Ltd
Develops radiopharmaceuticals that use targeted radiation to image and treat various cancers.
TLX | US
Overview
Corporate Details
- ISIN(s):
- AU000000TLX2
- LEI:
- Country:
- United States of America
- Address:
- 55 FLEMINGTON ROAD, 3051 NORTH MELBOURNE
- Website:
- https://telixpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Telix Pharmaceuticals Ltd. is a commercial-stage biopharmaceutical company specializing in the development and commercialization of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. The company's core approach involves using targeted radiation to both image and treat various forms of cancer. Its extensive pipeline addresses urologic oncology (prostate and kidney), neuro-oncology (glioma), and musculoskeletal oncology (sarcoma). Telix has achieved global regulatory approvals, including from the U.S. FDA, for its prostate cancer imaging agent and supports its portfolio with a robust global supply, manufacturing, and distribution network.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Telix Pharmaceuticals Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Telix Pharmaceuticals Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Telix Pharmaceuticals Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
